n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone has been researched along with oxotremorine m in 1 studies
Studies (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Trials (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Recent Studies (post-2010) (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Studies (oxotremorine m) | Trials (oxotremorine m) | Recent Studies (post-2010) (oxotremorine m) |
---|---|---|---|---|---|
15 | 0 | 0 | 186 | 0 | 35 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehlert, FJ | 1 |
1 other study(ies) available for n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone and oxotremorine m
Article | Year |
---|---|
Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
Topics: Adenylyl Cyclases; Animals; Aziridines; Azirines; Guanosine Triphosphate; Heart Rate; Male; Mathematics; Myocardium; N-Methylscopolamine; Oxotremorine; Pyrrolidinones; Rabbits; Receptors, Muscarinic; Scopolamine Derivatives | 1987 |